Epithelial-mesenchymal transition in cancer

[1]  Saugata Hazra,et al.  The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective , 2019, Journal of cellular physiology.

[2]  P. Majumder,et al.  Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance , 2019, Science Signaling.

[3]  J. Dai,et al.  Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis , 2019, Science Advances.

[4]  Shivashankar H. Nagaraj,et al.  Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer , 2019, Journal of clinical medicine.

[5]  J. Onuchic,et al.  Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response , 2019, Journal of clinical medicine.

[6]  R. Weinberg,et al.  Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells , 2019, Proceedings of the National Academy of Sciences.

[7]  Sean C. Bendall,et al.  Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution , 2019, Nature Communications.

[8]  J. Onuchic,et al.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways , 2019, Proceedings of the National Academy of Sciences.

[9]  M. Jolly,et al.  Stability and mean residence times for hybrid epithelial/mesenchymal phenotype , 2019, Physical biology.

[10]  Yang Shen,et al.  Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. , 2018, Cancer discovery.

[11]  Jason T. George,et al.  NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype , 2018, bioRxiv.

[12]  Michael D. Brooks,et al.  Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. , 2018, Cell metabolism.

[13]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[14]  S. Zapperi,et al.  Topography of epithelial–mesenchymal plasticity , 2018, Proceedings of the National Academy of Sciences.

[15]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[16]  H. Levine,et al.  Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States , 2018, Cells.

[17]  Jason T. George,et al.  Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer , 2018, bioRxiv.

[18]  Mohit Kumar Jolly,et al.  Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. , 2017, Cancer research.

[19]  J. Onuchic,et al.  Numb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling , 2017, Journal of The Royal Society Interface.

[20]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[21]  C. Frezza,et al.  Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer , 2017, The FEBS journal.

[22]  Prakash Kulkarni,et al.  Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory , 2017, Cancers.

[23]  F. Kruyt,et al.  EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities , 2017, Molecular oncology.

[24]  Brendan J. McConkey,et al.  The GRHL2/ZEB Feedback Loop—A Key Axis in the Regulation of EMT in Breast Cancer , 2017, Journal of cellular biochemistry.

[25]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[26]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[27]  Jianpeng Ma,et al.  Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation. , 2017, Cancer research.

[28]  H. Levine,et al.  EMT and MET: necessary or permissive for metastasis? , 2017, bioRxiv.

[29]  W. Woodward,et al.  Inflammatory breast cancer: a model for investigating cluster-based dissemination , 2017, npj Breast Cancer.

[30]  E. Ben-Jacob,et al.  Distinguishing mechanisms underlying EMT tristability , 2017, bioRxiv.

[31]  H. Ishii,et al.  Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer , 2016, Scientific Reports.

[32]  Bin Huang,et al.  Interrogating the topological robustness of gene regulatory circuits by randomization , 2016, bioRxiv.

[33]  Emanuel J. V. Gonçalves,et al.  Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition , 2016, Nature.

[34]  M. Garcia-Blanco,et al.  Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2 , 2016, Molecular and Cellular Biology.

[35]  Qing Nie,et al.  Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit. , 2016, Physical chemistry chemical physics : PCCP.

[36]  E. Ben-Jacob,et al.  Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype , 2016, Journal of The Royal Society Interface.

[37]  E. Ben-Jacob,et al.  Stability of the hybrid epithelial/mesenchymal phenotype , 2016, Oncotarget.

[38]  James E. Verdone,et al.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters , 2016, Proceedings of the National Academy of Sciences.

[39]  L. Tran,et al.  HDAC Inhibition Impedes Epithelial-Mesenchymal Plasticity and Suppresses Metastatic, Castration-Resistant Prostate Cancer , 2015, Oncogene.

[40]  Reka Albert,et al.  Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes , 2015, npj Systems Biology and Applications.

[41]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[42]  R. Weinberg,et al.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. , 2015, Trends in cell biology.

[43]  Jeffrey D. Varner,et al.  Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1 , 2015, bioRxiv.

[44]  Eshel Ben-Jacob,et al.  Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model , 2015, Oncotarget.

[45]  E. Ben-Jacob,et al.  Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision , 2015, Proceedings of the National Academy of Sciences.

[46]  E. Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[47]  Xudong Dai,et al.  Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. , 2015, Cancer research.

[48]  Eshel Ben-Jacob,et al.  OVOL guides the epithelial-hybrid-mesenchymal transition , 2015, Oncotarget.

[49]  A. Zaravinos.  The Regulatory Role of MicroRNAs in EMT and Cancer , 2015, Journal of oncology.

[50]  G. McArthur,et al.  Phenotype Switching in Melanoma: Implications for Progression and Therapy , 2015, Front. Oncol..

[51]  D. Nam,et al.  Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling , 2014, OncoTargets and therapy.

[52]  Jingyu Zhang,et al.  TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops , 2014, Science Signaling.

[53]  T. Copetti,et al.  A mitochondrial switch promotes tumor metastasis. , 2014, Cell reports.

[54]  S. Baylin,et al.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.

[55]  Jing Yang,et al.  Ovol proteins: guardians against EMT during epithelial differentiation. , 2014, Developmental cell.

[56]  Shamik Sen,et al.  Extracellular matrix density promotes EMT by weakening cell-cell adhesions. , 2014, Molecular bioSystems.

[57]  M. Nieto.  Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells , 2013, Science.

[58]  M Choolani,et al.  An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) , 2013, Cell Death and Disease.

[59]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[60]  H. Ford,et al.  Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. , 2013, Cancer research.

[61]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[62]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[63]  K. Rajagopalan,et al.  Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer , 2013, Journal of cellular biochemistry.

[64]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[65]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[66]  A. Menssen,et al.  miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions , 2011, Cell cycle.

[67]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[68]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[69]  M. Hung,et al.  p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs , 2010, Nature Cell Biology.

[70]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[71]  Celeste M Nelson,et al.  Tissue geometry patterns epithelial–mesenchymal transition via intercellular mechanotransduction , 2010, Journal of cellular biochemistry.

[72]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[73]  Hannah H. Chang,et al.  Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours , 2009, Nature Reviews Genetics.

[74]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[75]  Yunjung Choi,et al.  Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. , 2009, Lung cancer.

[76]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[77]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[78]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[79]  E. Brown,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. , 2005, Cancer research.

[80]  E. Carver,et al.  The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.

[81]  D G Wilkinson,et al.  Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.

[82]  E. Hay,et al.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.

[83]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2016 .

[84]  E. Grzybowska,et al.  CTC clusters in cancer progression and metastasis , 2016, Medical Oncology.

[85]  Andrew J Armstrong,et al.  Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .